Nephros Added to Russell Microcap Index, Gaining Automatic Style Inclusions
NEPH•Nephros, Inc. was added to the Russell Microcap® Index following FTSE Russell’s June 26, 2026 annual reconstitution, joining its growth and value style indexes for one year. The Russell Microcap Index underpins approximately $10.6 trillion in benchmarked assets, potentially boosting Nephros’ visibility among institutional investors.
1. Inclusion Details
Nephros, Inc. achieved membership in the Russell Microcap® Index effective after the US market close on June 26, 2026, as part of FTSE Russell’s annual reconstitution. This inclusion secures a one-year placement in both growth and value style indexes, reflecting its market-capitalization ranking.
2. Potential Impact
Index inclusion often triggers passive fund inflows and elevates institutional awareness, with the Russell US family benchmarking roughly $10.6 trillion in assets. Nephros’ leadership anticipates increased investor visibility and expanded access to new shareholder segments following this milestone.
